Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000470368 | SCV000541508 | likely benign | Deafness-lymphedema-leukemia syndrome; Monocytopenia with susceptibility to infections | 2023-10-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001785615 | SCV002028194 | uncertain significance | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as a germline pathogenic or benign variant to our knowledge; This variant is associated with the following publications: (PMID: 30190467) |
Prevention |
RCV003418151 | SCV004118557 | uncertain significance | GATA2-related disorder | 2023-08-28 | criteria provided, single submitter | clinical testing | The GATA2 c.669G>A variant is predicted to result in the amino acid substitution p.Met223Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.049% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-128204772-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Baylor Genetics | RCV004567940 | SCV005058904 | uncertain significance | Acute myeloid leukemia | 2023-12-27 | criteria provided, single submitter | clinical testing |